Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05473663 · ClinicalTrials.gov registry record · NA

Radiofrequency Ablation After Total Knee Arthroplasty

A NA study of Chronic Knee Pain, sponsored by University of Massachusetts, Worcester.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05473663 is a NA study of Chronic Knee Pain that is active but no longer recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 14 participants, below the 231-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05473663, a NA study of Chronic Knee Pain, is active but no longer recruiting, sponsored by University of Massachusetts, Worcester.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess how clinically useful and safe genicular nerve radiofrequency ablation is in people with chronic pain after total knee arthroplasty performed for osteoarthritis.

Conditions Studied

Interventions

  • DEVICE Radiofrequency Ablation
  • DEVICE Sham

Study Locations (1)

Massachusetts

  • University of Massachusetts Chan Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-09-01
Est. Completion 2026-09-30
Phase NA

What the Registry Record Tells You About NCT05473663

The ClinicalTrials.gov registry entry for NCT05473663 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (94% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Knee Pain appearing as the primary indexed condition, and to 2 interventions - of which Radiofrequency Ablation is the first listed.

NCT05473663 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05473663 about?

NCT05473663 is a clinical study titled "Radiofrequency Ablation After Total Knee Arthroplasty". The purpose of this study is to assess how clinically useful and safe genicular nerve radiofrequency ablation is in people with chronic pain after total knee arthroplasty performed for osteoarthritis.

What is the current status of trial NCT05473663?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2022-09-01. Estimated completion is 2026-09-30.

What conditions does trial NCT05473663 study?

This clinical trial studies the following conditions: Chronic Knee Pain.

What interventions are being tested in trial NCT05473663?

The interventions under investigation include: Radiofrequency Ablation (DEVICE), Sham (DEVICE).

Who is sponsoring clinical trial NCT05473663?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05473663 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Knee Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.